Pentostatin in steroid refractory acute graft versus host disease.

被引：0
|
作者：
Jacobsohn, D [1 ]
Margolis, J [1 ]
Anders, V [1 ]
Phelps, M [1 ]
Grever, M [1 ]
Vogelsang, G [1 ]
机构：
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Bone Marrow Transplant Program, Baltimore, MD 21218 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1628
引用
收藏
页码：420A / 420A
页数：1
相关论文
共 50 条
  • [41] Tocilizumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease: A Pediatric Experience
    Bhatt, Sima
    Schulz, Ginny
    Towerman, Alison
    Hente, Monica
    Shenoy, Shalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S389 - S390
  • [42] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [43] Novel strategies for steroid-refractory acute graft-versus-host disease
    Bolaños-Meade, J
    Vogelsang, GB
    CURRENT OPINION IN HEMATOLOGY, 2005, 12 (01) : 40 - 44
  • [44] Treatment of severe steroid refractory acute graft versus host disease with infliximab.
    Magalhaes-Silverman, M
    Lee, CK
    Hohl, R
    Becker, A
    Gingrich, R
    BLOOD, 2001, 98 (11) : 359B - 359B
  • [45] Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease
    Agrawal, Vaibhav
    Griffin, Shawn P.
    Koch, Lindsey
    Thakrar, Teresa C.
    Ervin, Kirsten D.
    Schmidt, Caitlin A.
    Cox, Elizabeth A.
    Schwartz, Jennifer E.
    Abonour, Rafat
    Robertson, Michael J.
    Brinda, Bryan J.
    Nelson, Robert P., Jr.
    Farag, Sherif S.
    Abu Zaid, Mohammad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [46] SUPERIOR OVERALL SURVIVAL AFTER SIMULTANEOUS SALVAGE THERAPY BY PENTOSTATIN AND MYCOPHENOLATE MOFETIL FOR SEVERE INTESTINAL STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE
    Klein, S.
    Schmitt, T.
    Bug, G.
    Schetelig, J.
    Schwerdtfeger, R.
    Schaefer-Eckart, K.
    Schmid, C.
    Kobbe, G.
    Heidenreich, D.
    Ruehe, E.
    Bornhaeuser, M.
    Martin, H.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S307 - S308
  • [47] A multicentre retrospective analysis on pentostatin as salvage therapy of severe steroid refractory acute graft-versus-host disease of the gastro-intestinal tract
    Klein, S. A.
    Schmitt, T.
    Bug, G.
    Schetelig, J.
    Schwerdtfeger, R.
    Schaefer-Eckart, K.
    Schmid, C.
    Kobbe, G.
    Heidenreich, D.
    Bornhaeuser, M.
    Martin, H.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S150 - S150
  • [48] Steroid-refractory graft-versus-host disease. Extracorporeal irradiation of leucocytes induces immunotolerance
    Schinwald, N.
    Rank, A.
    Tischer, J.
    Kolb, H. J.
    INTERNIST, 2009, 50 (11): : 1270 - +
  • [49] Feasibility, safety and efficacy of Abatacept for steroid refractory acute graft-versus-host disease
    Yong, J.
    Patel, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 291 - 291
  • [50] How I treat steroid-refractory acute graft-versus-host disease
    Martin, Paul J.
    BLOOD, 2020, 135 (19) : 1630 - 1638
12345